ArticleMolecular metabolism2024

Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events.

Pavel Burda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.